Skip to main content

Advertisement

SpringerLink
Log in

Hyperserotoninemia and Altered Immunity in Autism

  • Original Paper
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

One of the most consistent biological findings in autism is elevated whole blood serotonin (5-HT) levels found in about 1/3 of cases. Immune abnormalities are also commonly observed in this disorder. Given 5-HT’s role as an immunomodulator, possible connections between 5-HT and immune abnormalities in autism are explored in this review. Areas of focus include hyperserotoninemia and cellular immune function, autoantibodies to 5-HT receptors, and 5-HT’s role in autoimmunity. Further research is needed to determine the interactions between neuropsychiatric and immune dysfunction in autism and related disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abramson, R. K., Self, S., Genco, P., Smith, N., Pendleton, A., Valentine, J., Wright, H. H., Cuccaro, M., & Powell, D. (1990). The relationship between lymphocyte cell surface markers and serotonin in autistic probands. American Journal of Human Genetics, 47, A45.

    Google Scholar 

  • Ameisen, J. C., Meade, R., & Askenase, P. W. (1989). A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. Journal of Immunology, 142, 3171–3179.

    Google Scholar 

  • Anderson, G. M., Feibel, F. C., & Cohen, D. J. (1987a). Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Science, 40, 1063–1070.

    Article  Google Scholar 

  • Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987b). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900.

    Article  Google Scholar 

  • Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., Roubertoux, P. L., & Tordjman, S. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7, 831–836.

    Article  PubMed  Google Scholar 

  • Askenase, P. W., Herzog, W. R., Millet, I., Paliwal, V., Ramabhadran, R., Rochester, C., Geba, G. P., & Ptak, W. (1991). Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol, 4(Suppl 1), 25–42.

    Article  PubMed  Google Scholar 

  • Aune, T. M., Golden, H. W., McGrath, K. M. (1994). Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. Journal of Immunology, 153, 489–498.

    Google Scholar 

  • Aune, T. M., McGrath, K. M., Sarr, T., Bombara, M. P. & Kelley, K. A. (1993). Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. Journal of Immunology, 151, 1175–1183.

    Google Scholar 

  • Betancur, C., Corbex, M., Spielewoy, C., Philippe, A., Laplanche, J. L., Launay, J. M., Gillberg, C., Mouren-Simeoni, M. C., Hamon, M., Giros, B., Nosten-Bertrand, M., & Leboyer, M. (2002). Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry, 7, 67–71.

    Article  PubMed  Google Scholar 

  • Black, C., Kaye, J. A., & Jick, H. (2002). Relation of childhood gastrointestinal disorders to autism: Nested case-control study using data from the UK General Practice Research Database. BMJ, 325, 419–421.

    Article  PubMed  Google Scholar 

  • Bonnet, M., Lespinats, G., & Burtin, C. (1984). Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells. Cell Immunology, 83, 280–291.

    Article  Google Scholar 

  • Chess, S., (1971). Autism in children with congenital rubella. Journal of Autism and Childhood Schizophrenia, 1, 33–47.

    Article  PubMed  Google Scholar 

  • Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.

    Article  PubMed  Google Scholar 

  • Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., da Silva, E. A., & Chugani, H. T. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666–669.

    Article  PubMed  Google Scholar 

  • Cohen, D. J., Shaywitz, B. A., Johnson, W. T., & Bowers, M., Jr. (1974). Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Archives of General Psychiatry, 31, 845–853.

    Google Scholar 

  • Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14, 388–394.

    Article  PubMed  Google Scholar 

  • Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607–613.

    Article  PubMed  Google Scholar 

  • Cook, E. H., Jr., Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., Sklena, P. J., Charak, D. A., & Leventhal, B. L. (1993a). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Science, 52, 2005–2015.

  • Cook, E. H., Jr., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., & Leventhal, B. L. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2, 247–250.

    Google Scholar 

  • Cook, E. H., Jr., Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488–491.

    Google Scholar 

  • Cook, E. H., Jr., Leventhal, B. L., Heller, W., Metz, J., Wainwright, M., & Freedman, D. X. (1990). Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268–274.

    Google Scholar 

  • Cook, E. H., Jr., Perry, B. D., Dawson, G., Wainwright, M. S., & Leventhal, B. L. (1993b). Receptor inhibition by immunoglobulins: Specific inhibition by autistic children, their relatives, and control subjects. Journal of Autism and Developmental Disorders, 23, 67–78.

    Google Scholar 

  • Courchesne, E., Carper, R., & Akshoomoff, N. (2003). Evidence of brain overgrowth in the first year of life in autism. JAMA, 290, 337–344.

    Article  PubMed  Google Scholar 

  • Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., Van der, P. M., Scharpe, S., Deboutte, D., Pison, G., & Maes, M. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.

    Google Scholar 

  • Curin, J. M., Terzic, J., Petkovic, Z. B., Zekan, L., Terzic, I. M., & Susnjara, I. M. (2003). Lower cortisol and higher ACTH levels in individuals with autism. Journal of Autism and Developmental Disorders, 33, 443–448.

    Article  PubMed  Google Scholar 

  • DeFelice, M. L., Ruchelli, E. D., Markowitz, J. E., Strogatz, M., Reddy, K. P., Kadivar, K., Mulberg, A. E., & Brown, K. A. (2003). Intestinal cytokines in children with pervasive developmental disorders. American Journal of Gastroenterology, 98, 1777–1782.

    Article  PubMed  Google Scholar 

  • DelGiudice-Asch, G., & Hollander, E. (1997). Altered immune function in autism. CNS Spectrums, 2, 61–67.

    Google Scholar 

  • Denney, D. R., Frei, B. W., & Gaffney, G. R. (1996). Lymphocyte subsets and interleukin-2 receptors in autistic children. Journal of Autism and Developmental Disorders, 26, 87–97.

    Article  PubMed  Google Scholar 

  • Dietsch, G. N., & Hinrichs, D. J. (1989). The role of mast cells in the elicitation of experimental allergic encephalomyelitis. Journal of Immunology, 142, 1476–1481.

    Google Scholar 

  • Folstein, S., & Rutter, M. (1977). Infantile autism: A genetic study of 21 twin pairs. Journal of Child Psychology and Psychiatry, 18, 297–321.

    Article  PubMed  Google Scholar 

  • Foon, K. A., Wahl, S. M., Oppenheim, J. J., & Rosenstreich, D. L. (1976). Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes. Journal of Immunology, 117, 1545–1552.

    Google Scholar 

  • Gabrilovac, J., Cicin-Sain, L., Osmak, M., & Jernej, B. (1992). Alteration of NK- and ADCC-activities in rats genetically selected for low or high platelet serotonin level. Journal of Neuroimmunology, 37, 213–222.

    Article  PubMed  Google Scholar 

  • Geba, G. P., Ptak, W., Anderson, G. M., Paliwal, V., Ratzlaff, R. E., Levin, J., & Askenase, P. W. (1996). Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. Journal of Immunology, 157, 557–565.

    Google Scholar 

  • Gillberg, C., Svennerholm, L., & Hamilton-Hellberg, C. (1983). Childhood psychosis and monoamine metabolites in spinal fluid. Journal of Autism and Developmental Disorders, 13, 383–396.

    Article  PubMed  Google Scholar 

  • Gray, R. S., McCorkle, F. M., Denno, K. M., & Taylor, R. L., Jr. (1991). Modulation of chicken plaque-forming cells by serotonin and dopamine. Poultry Science, 70, 1521–1526.

    Google Scholar 

  • Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34, 521–531.

    PubMed  Google Scholar 

  • Hellstrand, K., Czerkinsky, C., Ricksten, A., Jansson, B., Asea, A., Kylefjord, H., & Hermodsson, S. (1993). Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. Journal of Interferon Research, 13, 33–38.

    PubMed  Google Scholar 

  • Hellstrand, K., & Hermodsson, S. (1987). Role of serotonin in the regulation of human natural killer cell cytotoxicity. Journal of Immunology, 139, 869–875.

    Google Scholar 

  • Hellstrand, K., & Hermodsson, S. (1990). Enhancement of human natural killer cell cytotoxicity by serotonin: Role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunology, 127, 199–214.

    Article  Google Scholar 

  • Henson, P. M., & Spiegelberg, H. L. (1973). Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. Journal of Clinical Investigation, 52, 1282–1288.

    Article  PubMed  Google Scholar 

  • Hérault, J., Petit, E., Martineau, J., Cherpi, C., Perrot, A., Barthélémy, C., Lelord, G., & Müh, J. P. (1996). Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research, 65, 33–43.

    Article  PubMed  Google Scholar 

  • Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics, 135, 559–563.

    Article  PubMed  Google Scholar 

  • Huh, G. S., Boulanger, L. M., Du, H., Riquelme, P. A., Brotz, T. M., & Shatz, C. J. (2000). Functional requirement for class I MHC in CNS development and plasticity. Science, 290, 2155–2159.

    Article  PubMed  Google Scholar 

  • Jackson, J. C., Cross, R. J., Walker, R. F., Markesbery, W. R., Brooks, W. H., & Roszman, T. L. (1985). Influence of serotonin on the immune response. Immunology, 54, 505–512.

    PubMed  Google Scholar 

  • Jackson, J. C., Walker, R. F., Brooks, W. H., & Roszman, T. L. (1988). Specific uptake of serotonin by murine macrophages. Life Science, 42, 1641–1650.

    Article  Google Scholar 

  • Kemper, T. L., Bauman, M. (1998). Neuropathology of infantile autism. Journal of Neuropathology and Experimental Neurology, 57, 645–652.

    Article  PubMed  Google Scholar 

  • Khan, N.-A., & Poisson, J.-P. (1999). 5-HT3 receptor-channels coupled with Na+ influx in human T cells: Role in T cell activation. Journal of Neuroimmunology, 99, 53–60.

    Article  PubMed  Google Scholar 

  • Klareskog, L., Forsum, U., Scheynius, A., Kabelitz, D., & Wigzell, H. (1982). Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the USA, 79, 3632–3636.

    Article  PubMed  Google Scholar 

  • Klauck, S. M., Poustka, F., Benner, A., Lesch, K. P., & Poustka, A. (1997). Serotonin transporter (5-HTT) gene variants associated with autism? Human Molecular Genetics, 6, 2233–2238.

    Article  PubMed  Google Scholar 

  • Kuperman, S., Beeghly, J. H., Burns, T. L., & Tsai, L. Y. (1985). Serotonin relationships of autistic probands and their first-degree relatives. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 186–190.

    Article  Google Scholar 

  • Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., & Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527–1531.

    Article  PubMed  Google Scholar 

  • Linden, D. R., Chen, J.-X., Gershon, M. D., Sharkey, K. A., & Mawe, G. M. (2003). Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 285, G207–G216.

    PubMed  Google Scholar 

  • Maestrini, E., Lai, C., Marlow, A., Matthews, N., Wallace, S., Bailey, A., Cook, E. H., Jr., Weeks, D. E., & Monaco, A. P. (1999). Serotonin transporter (5-HTT) and γ-aminobutyric acid receptor subunit β3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. American Journal of Medical Genetics, 88, 492–496.

    Google Scholar 

  • Marchetti, B., Scifo, R., Batticane, N., & Scapagnini, U. (1990). Immunological significance of opioid peptide dysfunction in infantile autism. Brain Dysfunction, 3, 346–354.

    Google Scholar 

  • Mårtensson, U., & Nässberger, L. (1993). Influence of antidepressants on mitogen stimulation of human lymphocytes. Toxic in Vitro, 7, 241–245.

    Article  Google Scholar 

  • McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., Shapiro, T., & Cohen, D. J. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776.

    Article  PubMed  Google Scholar 

  • McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., & Mann, J. J. (1989). Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Archives of General Psychiatry, 46, 213–221.

    PubMed  Google Scholar 

  • McDougle, C. J., Holmes, J. P., Carlson, D. C., Pelton, G. H., Cohen, D. J., & Price, L. H. (1998). A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633–641.

    Article  PubMed  Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996a). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993–1000.

    Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996b). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.

    Google Scholar 

  • Ménage, P., Thibault, G., Barthélémy, C., Lelord, G., & Bardos, P. (1992). CD4+ CD45RA+ T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunction, 5, 326–333.

    Google Scholar 

  • Minderaa, R. B., Anderson, G. M., Volkmar, F. R., Akkerhuis, G. W., & Cohen, D. J. (1987). Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biological Psychiatry, 22, 933–940.

    Article  PubMed  Google Scholar 

  • Money, J., Bobrow, N. A., & Clarke, F. C. (1971). Autism and autoimmune disease: A family study. Journal of Autism and Childhood Schizophrenia, 1, 146–160.

    Article  PubMed  Google Scholar 

  • Mössner, R., & Lesch, K.-P. (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behavior and Immunity, 12, 249–271.

    Article  Google Scholar 

  • Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., Minderaa, R. B. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491–499.

    Article  PubMed  Google Scholar 

  • Paegelow, I., Werner, H., Hagen, M., Wartner, U., & Lange, P. (1985). Influence of serotonin on lymphokine secretion in vitro. International Journal of Immunopharmacology, 7, 889–896.

    Article  PubMed  Google Scholar 

  • Perry, B. D., Cook, E. H., Jr., Leventhal, B. L., Wainwright, M. S., & Freedman, D. X. (1991). Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives. Biological Psychiatry, 30, 121–130.

    Google Scholar 

  • Persico, A. M., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., Conciatori, M., Damiani, V., Baldi, A., & Keller, F. (2000). Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. American Journal of Medical Genetics, 96, 123–127.

    Article  PubMed  Google Scholar 

  • Plioplys, A. V. (1998). Intravenous immunoglobulin treatment of children with autism. Journal of Child Neurology, 13, 79–82.

    Article  PubMed  Google Scholar 

  • Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Lymphocyte function in autism and Rett syndrome. Neuropsychobiology, 29, 12–16.

    Article  PubMed  Google Scholar 

  • Poljak-Blazi, M., Jernej, B., Cicin-Sain, L., Boranic, M. (1990). Immunological response of rats selected for high or low platelet serotonin content. Periodicum Biologorum, 92, 189–190.

    Google Scholar 

  • Rogers, T., Kalaydjieva, L., Hallmayer, J., Petersen, P. B., Nicholas, P., Pingree, C., McMahon, W. M., Spiker, D., Lotspeich, L., Kraemer, H., McCague, P., Dimiceli, S., Nouri, N., Peachy, T., Yang, J., Hinds, D., Risch, N., & Myers, R.M. (1999). Exclusion of linkage to the HLA region in ninety multiplex sibships with autism. Journal of Autism and Developmental Disorders, 29, 195–201.

    Article  PubMed  Google Scholar 

  • Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315–320.

    Article  PubMed  Google Scholar 

  • Scifo, R., Cioni, M., Nicolosi, A., Batticane, N., Tirolo, C., Testa, N., Quattropani, M. C., Morale, M. C., Gallo, F., & Marchetti, B. (1996). Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Annali dell’Istituo Superiore di Sanita, 32, 351–359.

    Google Scholar 

  • Singh, V. K., & Rivas, W. H. (2004). Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Letters, 355, 53–56.

    Article  PubMed  Google Scholar 

  • Singh, V. K., Singh, E. A., & Warren, R. P. (1997). Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biological Psychiatry, 41, 753–755.

    Article  PubMed  Google Scholar 

  • Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunity, 7, 97–103.

    Article  Google Scholar 

  • Singh, V. K., Warren, R. P., & Singh, E. A. (1990). Binding of 3H serotonin to lymphocytes in patients with neuropsychiatric disorders. Molecular and Chemical Neuropathology, 13, 167–173.

    Article  PubMed  Google Scholar 

  • Slauson, D. O., Walker, C., Kristensen, F., Wang, Y., & de Weck, A. L. (1984). Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell Immunology, 84, 240–252.

    Article  Google Scholar 

  • Sternberg, E. M., Trial, J., & Parker, C. W. (1986). Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. Journal of Immunology, 137, 276–282.

    Google Scholar 

  • Stubbs, E.G. (1978). Autistic symptoms in a child with congenital cytomegalovirus infection. Journal of Autism and Childhood Schizophrenia, 8, 37–43.

    Article  PubMed  Google Scholar 

  • Stubbs, E. G., Crawford, M. L., Burger, D. R., Vandenbark, A. A. (1977). Depressed lymphocyte responsiveness in autistic children. Journal of Autism and Childhood Schizophrenia, 7, 49–55.

    Article  PubMed  Google Scholar 

  • Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420.

    Article  PubMed  Google Scholar 

  • Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2004). Autistic disorder in three children with cytomegalovirus infection. Journal of Autism and Developmental Disorders, 34, 583–586.

    Article  PubMed  Google Scholar 

  • Sweeten, T. L., Posey, D. J., Shekhar, A., & McDougle, C. J. (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacology Biochemistry and Behavior, 71, 449–455.

    Article  Google Scholar 

  • Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Sciences of the USA, 82, 612–616.

    Article  PubMed  Google Scholar 

  • Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A., & Odell, D. (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Human Immunology, 63, 311–316.

    Article  PubMed  Google Scholar 

  • van Gent, T., Heijnen, C. J., & Treffers, P. D. (1997). Autism and the immune system. Journal of Child Psychology and Psychiatry, 38, 337–349.

    Article  PubMed  Google Scholar 

  • Veenstra-VanderWeele, J., Kim, S. J., Lord, C., Courchesne, R., Akshoomoff, N., Leventhal, B. L., Courchesne, E., & Cook, E. H., Jr. (2002). Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. American Journal of Medical Genetics, 114, 277–283.

    Google Scholar 

  • Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., Montgomery, S. M., Davies, S., O’Leary, J. J., Berelowitz, M., & Walker-Smith, J. A. (2000). Enterocolitis in children with developmental disorders. American Journal Gastroenterology, 95, 2285–2295.

    Article  Google Scholar 

  • Walther, D. J., Peter, J. U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H., & Bader, M. (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 76.

    Article  PubMed  Google Scholar 

  • Warren, R. P., Foster A. & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335

    Article  PubMed  Google Scholar 

  • Warren, R. P., Kane, K. K., Burger, R. A., Singh, V. K. (1990). Serotonin-induced suppression of lymphocyte DNA synthesis and natural killer cell activity. Annals of the New York Academy of Sciences, 594, 429–431.

    Article  Google Scholar 

  • Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189–197.

    Article  PubMed  Google Scholar 

  • Warren, R. P., & Singh, V. K. (1996). Elevated serotonin levels in autism: Association with the major histocompatibility complex. Neuropsychobiology, 34, 72–75.

    Article  PubMed  Google Scholar 

  • Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., DeWitt, C. W., & McCullough, M. (1992). Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics, 36, 203–207.

    Article  PubMed  Google Scholar 

  • Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (1995). DR-positive T cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology, 31, 53–57.

    Article  PubMed  Google Scholar 

  • Yirmiya, N., Pilowsky, T., Nemanov, L., Arbelle, S., Feinsilver, T., Fried, I., Ebstein, R. P. (2001). Evidence for an association with the serotonin transporter promoter region polymorphism and autism. American Journal of Medical Genetics, 105, 381–386.

    Article  PubMed  Google Scholar 

  • Young, M. R. I., Kut, J. L., Coogan, M. P., Wright, M. A., Young, M. E., & Matthews, J. (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology, 80, 395–400.

    PubMed  Google Scholar 

  • Yuwiler, A., Shih, J. C., Chen, C. H., Ritvo, E. R., Hanna, G., Ellison, G. W., & King, B. H. (1992). Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of Autism and Developmental Disorders, 22, 33–45.

    Article  PubMed  Google Scholar 

  • Zhong, N., Ye, L., Ju, W., Brown, W. T., Tsiouris, J., & Cohen, I. (1999). 5-HTTLPR variants not associated with autistic spectrum disorders. Neurogenetics, 2, 129–131.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Utah, 30 North 1900 East, 3R330 SOM, Salt Lake City, UT, 84132-2305, USA

    Nancy K. Burgess, Thayne L. Sweeten & Robert S. Fujinami

  2. Department of Psychiatry, University of Utah, 30 North 1900 East, 5R110 SOM, Salt Lake City, UT, 84132, USA

    William M. McMahon

Authors
  1. Nancy K. Burgess
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thayne L. Sweeten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William M. McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert S. Fujinami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert S. Fujinami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burgess, N.K., Sweeten, T.L., McMahon, W.M. et al. Hyperserotoninemia and Altered Immunity in Autism. J Autism Dev Disord 36, 697–704 (2006). https://doi.org/10.1007/s10803-006-0100-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-006-0100-7

Keywords

Search

Navigation